United States Pharmacopeia (USP) Safety Review of <i>Gamma</i>-Aminobutyric Acid (GABA)

<i>Gamma</i>-amino butyric acid (GABA) is marketed in the U.S. as a dietary supplement. USP conducted a comprehensive safety evaluation of GABA by assessing clinical studies, adverse event information, and toxicology data. Clinical studies investigated the effect of pure GABA as a dietar...

Full description

Bibliographic Details
Main Authors: Hellen A. Oketch-Rabah, Emily F. Madden, Amy L. Roe, Joseph M. Betz
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Nutrients
Subjects:
Online Access:https://www.mdpi.com/2072-6643/13/8/2742

Similar Items